Quest Diagnostics Incorporated (DGX) financial statements (2020 and earlier)

Company profile

Business Address 500 PLAZA DRIVE
SECAUCUS, NJ 07094
State of Incorp. DE
Fiscal Year End December 31
SIC 8071 - Medical Laboratories (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,192135195410182192187
Cash and cash equivalents1,192135137359133192187
Short-term investments  585149  
Receivables1,0631,012924926901932852
Inventory, net of allowances, customer advances and progress billings1239995828411091
Inventory1239995828411091
Prepaid expense31437144144 
Disposal group, including discontinued operation   9176  
Other undisclosed current assets1091305590117325253
Total current assets:2,4901,3901,3061,5311,5011,6031,383
Noncurrent Assets
Operating lease, right-of-use asset518
Property, plant and equipment1,4531,2881,1451,029925933805
Long-term investments and receivables4824364624434736358
Long-term investments4824364624434736358
Intangible assets, net (including goodwill)7,7407,7707,4546,9496,8897,1036,545
Goodwill6,6196,5636,3356,0005,9056,0325,649
Intangible assets, net (excluding goodwill)1,1211,2071,1199499841,071896
Other noncurrent assets160119136148174238215
Other undisclosed noncurrent assets     (63)(58)
Total noncurrent assets:10,3539,6139,1978,5698,4618,2747,565
TOTAL ASSETS:12,84311,00310,50310,1009,9629,8778,948
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,0411,0211,0219751,0141,191920
Accounts payable263222224261279  
Accrued liabilities223274246254257  
Employee-related liabilities287249325316305364283
Taxes payable2717934637
Interest and dividends payable116118107108107  
Other undisclosed accounts payable and accrued liabilities1251411103362764630
Debt949464366159518212
Total current liabilities:1,9901,4851,0579811,1731,7091,132
Noncurrent Liabilities
Long-term debt and lease obligation, including:3,9663,4293,7483,7283,4923,2443,120
Long-term debt, excluding current maturities3,9663,4293,7483,7283,4923,244 
Finance lease, liability30
Operating lease, liability413
Other undisclosed long-term debt and lease obligation(443)     3,120
Liabilities, other than long-term debt711745663654514798915
Deferred tax liabilities, net    204192
Other liabilities711745663654514594723
Other undisclosed noncurrent liabilities413    (204)(192)
Total noncurrent liabilities:5,0904,1744,4114,3824,0063,8383,843
Total liabilities:7,0805,6595,4685,3635,1795,5474,975
Temporary equity, carrying amount7677807770  
Stockholders' equity
Stockholders' equity attributable to parent5,6415,2164,9214,6284,6844,3013,948
Common stock2222222
Treasury stock, value(5,218)(4,996)(4,783)(4,460)(3,960)(3,815)(3,783)
Additional paid in capital2,7222,6672,6122,5452,4812,4182,379
Accumulated other comprehensive loss(39)(59)(48)(72)(38)(27)(8)
Retained earnings8,1747,6027,1386,6136,1995,7235,358
Stockholders' equity attributable to noncontrolling interest46513432292925
Total stockholders' equity:5,6875,2674,9554,6604,7134,3303,973
TOTAL LIABILITIES AND EQUITY:12,84311,00310,50310,1009,9629,8778,948

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues7,7267,5317,7097,5157,4937,4357,146
Revenue, net7,5317,7097,5157,4937,4357,146
Cost of revenue(5,037)(4,926)(4,719)(4,616)(4,657)(4,637)(4,326)
Gross profit:2,6892,6052,9902,8992,8362,7982,820
Operating expenses(1,553)(1,518)(1,824)(1,635)(1,426)(2,255)(2,207)
Other operating income (expense), net9514(1)13(11)  
Other undisclosed operating income     440862
Operating income:1,2311,1011,1651,2771,3999831,475
Nonoperating expense(155)(175)(135)(191)(296)(134)(127)
Investment income, nonoperating     331
Other nonoperating income (expense)20(8)16(48)(143)48
Interest and debt expense(180)(169)(153)(144)   
Other undisclosed income from continuing operations before equity method investments, income taxes180169153144   
Income from continuing operations before equity method investments, income taxes:1,0769261,0301,0861,1038491,348
Income from equity method investments57443539232624
Income from continuing operations before income taxes:1,1339701,0651,1251,1268751,372
Income tax expense(247)(182)(241)(429)(373)(262)(500)
Other undisclosed loss from continuing operations     (26)(24)
Income from continuing operations:886788824696753587848
Income from discontinued operations20    535
Net income:906788824696753592883
Net loss attributable to noncontrolling interest(48)(52)(52)(51)(44)(36)(34)
Net income attributable to parent:858736772645709556849
Other undisclosed net loss available to common stockholders, basic (3)(3)(3)   
Net income available to common stockholders, diluted:858733769642709556849

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income:906788824696753592883
Other comprehensive income (loss)20(9)24(34)(11)(19)(22)
Comprehensive income:926779848662742573861
Comprehensive income (loss), net of tax, attributable to noncontrolling interest(48)(52)(52)(51)(44)3634
Other undisclosed comprehensive loss, net of tax, attributable to parent     (72)(68)
Comprehensive income, net of tax, attributable to parent:878727796611698537827

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: